Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Assessing Human Papillomavirus Self-Sampling Attitudes in Cisgender Women and Persons with a Cervix Living with Human Immunodeficiency Virus in Canada

FY 2024-25

Summary
Cervical cancer is the 4th most common cancer in women globally, with 660,000 reported cases in 2022. Human Papillomavirus (HPV) is the cause of almost all cervical cancers. Despite cervical cancer screening programs in Canada, cervical cancer rates have been increasing. Women living with HIV (WLWH) experience higher rates of HPV infection and cervical cancer than women without HIV. WLWH are also less likely to routinely screen for cervical cancer. Higher rates of gender-based violence, discrimination, and the stigma of an HIV diagnosis have all been reported as barriers to accessing testing within this population. The HPV DNA test detects an HPV infection in the vagina. HPV DNA tests can also be self-collected. We believe that HPV self-sampling will be a highly accepted method of testing among WLWH in Canada and will increase cervical cancer screening participation within this community. The objectives of this study are to determine WLWH thoughts, attitudes and perceptions of HPV self-sampling as a method of screening for cervical cancer. 450 WLWH aged 18-45 will be recruited from 11 study sites across Canada. Participants will be given a brief description of HPV self-sampling and instructions on how to use the test. Participants will be asked to complete a questionnaire to assess their perceptions and comfort of HPV self-sampling before they perform any HPV self-sampling. Responses will be based on a 5-point scale (where participants will choose from 5 potential answers ranging from strongly agree to strongly disagree) for each question. We will analyze any trends between participant characteristics and questionnaire responses. This research is important because it has the potential to increase cervical cancer screening participation within this population.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530291
Name
Nicolls Sofia N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing Human Papillomavirus Self-Sampling Attitudes in Cisgender Women and Persons with a Cervix Living with Human Immunodeficiency Virus in Canada
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cervical Cancer; Gynaecologic Cancer Prevention; Gynaecology; Health Equity; Hpv Dna Testing; Hpv Screening; Human Immunodeficiency Virus; Human Papillomavirus; Infectious Diseases; Screening Attitudes
Abstract
Cervical cancer is the 4th most common cancer in women globally, with 660,000 reported cases in 2022. Human Papillomavirus (HPV) is the cause of almost all cervical cancers. Despite cervical cancer screening programs in Canada, cervical cancer rates have been increasing. Women living with HIV (WLWH) experience higher rates of HPV infection and cervical cancer than women without HIV. WLWH are also less likely to routinely screen for cervical cancer. Higher rates of gender-based violence, discrimination, and the stigma of an HIV diagnosis have all been reported as barriers to accessing testing within this population. The HPV DNA test detects an HPV infection in the vagina. HPV DNA tests can also be self-collected. We believe that HPV self-sampling will be a highly accepted method of testing among WLWH in Canada and will increase cervical cancer screening participation within this community. The objectives of this study are to determine WLWH thoughts, attitudes and perceptions of HPV self-sampling as a method of screening for cervical cancer. 450 WLWH aged 18-45 will be recruited from 11 study sites across Canada. Participants will be given a brief description of HPV self-sampling and instructions on how to use the test. Participants will be asked to complete a questionnaire to assess their perceptions and comfort of HPV self-sampling before they perform any HPV self-sampling. Responses will be based on a 5-point scale (where participants will choose from 5 potential answers ranging from strongly agree to strongly disagree) for each question. We will analyze any trends between participant characteristics and questionnaire responses. This research is important because it has the potential to increase cervical cancer screening participation within this population.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nicolls, Sofia N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~